Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Integrative molecular characterization of breast cancer

ABSTRACT: Integrative molecular characterization of breast cancer

PROVIDER: PRJNA727874 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Integrative molecular characterization of genitourinary cancers

Project description:Integrative molecular characterization of genitourinary cancers

| PRJNA647005 | ENA

Integrative molecular characterization of genitourinary cancers

Project description:Integrative molecular characterization of genitourinary cancers

| PRJNA647004 | ENA

Molecular characterization of mucinous breast cancer by low-coverage WGS

Project description:Molecular characterization of mucinous breast cancer identifies epigenetic regulation of MUC2 as a driver of the disease.

2022-02-02 | E-MTAB-7256 | biostudies-arrayexpress

Molecular Characterization of Human Breast Tumor Microvessels

Project description:Molecular Characterization of Human Breast Tumor Microvessels Keywords: breast cancer

2007-04-03 | GSE7413 | GEO

Molecular characterization of Georgia cohort of primary breast cancer FFPE tissues on custom breast cancer DASL panel

Project description:Analysis of 143 formalin-fixed, paraffin-embedded (FFPE) primary breast tumors using a Custom Breast Cancer Panel and Human Cancer Panel for the DASL platform. Molecular markers between the pathology defined subtypes of breast cancer were assessed to hypothesize potential therapeutic targets specific to the subtypes Molecular Characterization of 143 primary breast carcinomas including 101 triple negative (TN: ER-, PR-, HER2-), 3 HER2-positive (HER2+: ER-, PR-, HER2+), and 39 hormone receptor-positive (HR+: ER+ and/or PR+)

2009-10-23 | E-GEOD-18539 | biostudies-arrayexpress

Molecular characterization of mucinous breast cancer by low-coverage WGS

Project description:Molecular characterization of mucinous breast cancer by low-coverage WGS

| PRJEB28880 | ENA

Molecular characterization of Quebec Cohort of Primary Breast Cancer FFPE Tissues on the Human Cancer Panel

Project description:Analysis of 97 formalin-fixed, paraffin-embedded (FFPE) primary breast tumors using Illumina DASL microarray technology on a Custom Breast Cancer Panel and the Illumina Human Cancer Panel. Molecular markers between the pathology defined subtypes of breast cancer were assessed to hypothesize potential therapeutic targets specific to the subtypes Molecular Characterization of 97 primary breast tumor formalin-fixed, paraffin-embedded (FFPE) specimens including 24 triple negative (TN: ER-, PR-, HER2-), 9 HER2-positive (HER2+: ER-, PR-, HER2+), and 64 hormone receptor-positive (HR+: ER+ and/or PR+). 91 of the 97 specimens were characterized on the Illumina Human Cancer DASL Panel and 86 of 97 specimens were characterized on a custom Breast Cancer DASL Panel, 80 of these specimens were common to both the Human Cancer DASL Panel and the custom Breast Cancer DASL Panel.

2009-10-23 | E-GEOD-17650 | biostudies-arrayexpress

Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer

Project description:This SuperSeries is composed of the following subset Series: GSE32676: Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer [mRNA] GSE32678: Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer [miRNA] GSE32682: Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer [SNP] Refer to individual Series

2011-10-07 | E-GEOD-32688 | biostudies-arrayexpress

Molecular Determinants of Post-Mastectomy Breast Cancer Recurrence

Project description:Molecular Determinants of Post-Mastectomy Breast Cancer Recurrence

2018-09-20 | PRJEB28702 | EVA

Integrative Clinical and Molecular Characterization of Translocation Renal Cell Carcinoma

Project description:Integrative Clinical and Molecular Characterization of Translocation Renal Cell Carcinoma

| PRJNA780561 | ENA